Grigorios Papageorgiou

Convalescent Plasma for COVID-19. A randomized clinical trial

Arvind Gharbharan, Carlijn Jordans, Corine H. GeurtsvanKessel et al. · medRxiv · 2020 · 240 citations · Full text

Life Sciences, Immunology, Infectious Diseases +9

Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection

Arvind Gharbharan, Carlijn Jordans, Corine H. GeurtsvanKessel et al. · Nature Communications · 2021 · 160 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13

Statistical primer: how to deal with missing data in scientific research?†

Grigorios Papageorgiou, Stuart W Grant, Johanna J.M. Takkenberg et al. · Interactive Cardiovascular and Thoracic Surgery · 2018 · 151 citations · Full text

Public Health, Biostatistics, Epidemiologic Methods +16

An Overview of Joint Modeling of Time-to-Event and Longitudinal Outcomes

Grigorios Papageorgiou, Katya Mauff, Anirudh Tomer et al. · Annual Review of Statistics and Its Application · 2018 · 146 citations · Full text

Public Health, Biostatistics, Data Science +14

Clinical Characteristics and Outcomes of Immunocompromised Patients With Coronavirus Disease 2019 Caused by the Omicron Variant: A Prospective, Observational Study

S. Reshwan K. Malahe, Rogier A.S. Hoek, Virgil A. S. H. Dalm et al. · Clinical Infectious Diseases · 2022 · 84 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14